G-Con was founded on the premise that existing equipment,
modules and methodologies for constructing biomanufacturing
suites are not affordable, flexible, or robust enough to meet
the rapidly changing needs of the market. As biotherapeutic
developers, G-Con's founders experienced
the high cost to build and maintain
traditional facilities, and their
inherent lack of flexibility.
Leveraging that experience, we created the G-Con Pod solution.